authors
- Russo, R I Cordo
- Beguelin, Wendy
- Flaqué, M C Díaz
- Proietti, C J
- Venturutti, L
- Galigniana, N
- Tkach, M
- Guzmán, P
- Roa, J C
- O'Brien, N A
- Charreau, E H
- Schillaci, R
- Elizalde, P V
Correction: Targeting ErbB-2 nuclear localization and function inhibits breast cancer growth and overcomes trastuzumab resistance.
Overview
publication date
- October 1, 2023
published in
- Oncogene Journal
Identity
Scopus Document Identifier
- 85170099790
Digital Object Identifier (DOI)
- 10.1038/s41388-023-02832-1
PubMed ID
- 37684410
Additional Document Info
volume
- 42
issue
- 42